Yunfeng Capital

Yunfeng Capital is a Chinese venture capital firm that has been particularly active in technology and AI-related investments. The firm co-led a 1.5 billion yuan Series A+ round in Spirit AI in April 2026 alongside Shunwei Capital , and has made multiple bets in the quantum computing, robotics, and semiconductor sectors — including investments in neutral-atom quantum startup MatriQ's A+ round , D-Robotics across several funding rounds , and general-purpose robotics company Flexiv's $100 million-plus Series B in 2020 . Its portfolio also spans healthcare, where it co-led AXBIO's round with AstraZeneca's CICC healthcare fund , and consumer, where it co-led building-block brand Blokees' 600 million yuan Series B with Legend Capital . Na Li has served as a managing director at the firm since at least 2017 . The firm's activity visible in elsewhere's corpus clusters from 2017 through 2026, with notable concentration in AI infrastructure, embodied intelligence, and hard tech.